fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with bms 806 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hubicki, AM; Madani, N; Perdigoto, AL; Sodroski, J; Springer, M | 1 |
1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and bms 806
Article | Year |
---|---|
Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry.
Topics: Animals; Cell Line; Cytopathogenic Effect, Viral; Dogs; Enfuvirtide; Ethers; Gene Products, env; HIV Envelope Protein gp41; HIV-1; Humans; Hydrocarbons, Fluorinated; Membrane Fusion; Molecular Weight; Peptide Fragments; Piperazines | 2007 |